Mayinglong International Pharmaceutical Development

Mayinglong International Pharmaceutical Development is the international research and development arm of the Mayinglong Pharmaceutical Group, a renowned Chinese pharmaceutical company with a history dating back to 1582. The company specializes in proctological treatments, most notably its market-leading Musk Hemorrhoids Ointment, and has diversified into dermatology and ophthalmology. Based in New Jersey, the international division focuses on bridging Traditional Chinese Medicine (TCM) with Western regulatory standards and expanding the brand's global footprint. Their product portfolio includes a range of OTC and prescription medications for hemorrhoids, anal fissures, and skin care. The company is a leader in the Chinese proctological market and continues to invest in modernizing ancient formulas through rigorous clinical research.